If monthly manipulation is to keep on occuring, is it in the best interests of shareholders to continue with this funding arrangement?
We are not bound to them in any way, and can seek finance elsewhere if Im not mistaken? Given that the Dendreon decision has derisked Prima to a certain extent, I think that in the interests of shareholders and the Company, alternative funding should be strongly sought!
Maybe that is what Martin Rogers is doing at the Bio Conference this week? I sure hope so.
If it werent for this blatant manipulation(is it even legal), IMO the SP would be a LOT higher!
What are your thoughts?
is springtree the best option
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |